PFO
EW icon

Pathstone Family Office’s Edwards Lifesciences EW Stock Holding History

Pathstone Family Office’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.89M Buy
41,137
+15,065
+58% +$1.21M 0.02% 394
2023
Q2 		$2.69M Buy
26,072
+1,301
+5% +$113K 0.04% 267
2023
Q1 		$1.99M Sell
24,771
-41,717
-63% -$3.28M 0.03% 288
2022
Q4 		$3.72M Buy
66,488
+14,020
+27% +$1.08M 0.03% 338
2022
Q3 		$4.44M Buy
52,468
+35,264
+205% +$3.39M 0.04% 256
2022
Q2 		$1.64M Sell
17,204
-3,687
-18% -$382K 0.04% 239
2022
Q1 		$2.53M Buy
20,891
+13,131
+169% +$1.47M 0.06% 150
2021
Q4 		$1M Buy
7,760
+2,490
+47% +$290K 0.03% 335
2021
Q3 		$598K Buy
5,270
+1,205
+30% +$138K 0.02% 452
2021
Q2 		$421K Buy
+4,065
New +$383K 0.01% 533
2021
Q1 		– Sell
-541
Closed -$49K – 884
2020
Q4 		$49K Buy
541
+535
+8,917% +$44.4K ﹤0.01% 516
2020
Q3 		$0 Hold
6
– – ﹤0.01% 860
2020
Q2 		$0 Hold
6
– – ﹤0.01% 797
2020
Q1 		$0 Buy
+6
New +$433 ﹤0.01% 779
2019
Q2 		– Sell
-39
Closed -$2K – 715
2019
Q1 		$2K Sell
39
-2,238
-98% -$128K ﹤0.01% 760
2018
Q4 		$116K Buy
+2,277
New +$115K 0.03% 119
2017
Q3 		– Sell
-3,000
Closed -$118K – 226
2017
Q2 		$118K Sell
3,000
-30
-1% -$1.09K 0.05% 143
2017
Q1 		$95K Buy
+3,030
New +$94.9K 0.05% 135
2013
Q3 		– Sell
-126
Closed -$1K – 343
2013
Q2 		$1K Buy
+126
New +$1.49K ﹤0.01% 352

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Pathstone Family Office's EW Position: Q3 2023 in Review

Pathstone Family Office increased its Edwards Lifesciences (EW) stake by 58% in Q3 2023, buying an estimated $1.21M and bringing the position to 41,137 shares worth $2.89M. The position accounts for 0.02% of the portfolio, ranked #394.

Pathstone Family Office first reported a position in EW in Q2 2013 and has held it in 19 quarters since. The position peaked at $4.44M in Q3 2022. 1,219 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Pathstone Family Office held 41,137 shares of Edwards Lifesciences worth $2.89M as of Q3 2023.
  • Pathstone Family Office bought 15,065 Edwards Lifesciences shares in Q3 2023, an estimated $1.21M.
  • Edwards Lifesciences made up 0.02% of Pathstone Family Office's portfolio in Q3 2023, its #394 holding.
  • Pathstone Family Office first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 19 quarters since.
  • Pathstone Family Office's Edwards Lifesciences position peaked at $4.44M in Q3 2022.
  • 1,219 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.